StockData
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. (NERV) stock

NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$2.16−0.04 (-1.82%)

Close on Nov 17, 2026Market cap $103.14MP/E –Yield –

Minerva Neurosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Minerva Neurosciences's pe ratio was 2.9× on Oct 31, 2025, against 47.6× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Oct 31, 20252.9×−8.9
2021Jul 30, 202111.8×–

More Minerva Neurosciences figures

See a number that looks wrong?